1,416
Views
16
CrossRef citations to date
0
Altmetric
Research Article

Potentially severe drug–drug interactions among older people and associations in assisted living facilities in Finland: a cross-sectional study

, , , , , & show all
Pages 250-257 | Received 25 Aug 2014, Accepted 07 Apr 2016, Published online: 18 Jul 2016

References

  • Hosia-Randell HM, Muurinen SM, Pitkälä KH. Exposure to potentially inappropriate drugs and drug–drug interactions in elderly nursing home residents in Helsinki, Finland: a cross-sectional study. Drugs Aging. 2008;25:683–692.
  • Bjerrum L, Andersen M, Petersen G, et al. Exposure to potential drug interactions in primary health care. Scand J Prim Health Care. 2003;21:153–158.
  • Johnell K, Klarin I. The relationship between number of drugs and potential drug–drug interactions in the elderly: a study of over 600,000 elderly patients from the Swedish prescribed drug register. Drug Saf. 2007;30:911–918.
  • Nobili A, Pasina L, Tettamanti M, et al. Potentially severe drug interactions in elderly outpatients: results of an observational study of an administrative prescription database. J Clin Pharm Ther. 2009;34:377–386.
  • Secoli SR, Figueras A, Lebrão ML, et al. Risk of potential drug–drug interactions among Brazilian elderly: a population-based, cross-sectional study. Drugs Aging. 2010;27:759–770.
  • Teixeira JJ, Crozatti MT, dos Santos CA, et al. Potential drug–drug interactions in prescriptions to patients over 45 years of age in primary care, southern Brazil. PLoS One. 2012;7:e47062.
  • Janchawee B, Owatranporn T, Mahatthanatrakul W, et al. Clinical drug interactions in outpatients of a university hospital in Thailand. J Clin Pharm Ther. 2005;30:583–590.
  • Bakken MS, Ranhoff AH, Engeland A, et al. Inappropriate prescribing for older people admitted to an intermediate-care nursing home unit and hospital wards . Scand J Prim Health Care. 2012;30:169–175.
  • Jyrkkä J, Vartiainen L, Hartikainen S, et al. Increasing use of medicines in elderly persons: a five-year follow-up of the Kuopio 75 + study. Eur J Clin Pharmacol. 2006;62:151–158.
  • Malone DC, Hutchins DS, Haupert H, et al. Assessment of potential drug–drug interactions with a prescription claims database. Am J Health Syst Pharm. 2005;62:1983–1991.
  • Lin CF, Wang CY, Bai CH. Polypharmacy, aging and potential drug–drug interactions in outpatients in Taiwan: a retrospective computerized screening study. Drugs Aging. 2011;28:219–225.
  • Cruciol-Souza JM, Thomson JC. Prevalence of potential drug–drug interactions and its associated factors in a Brazilian teaching hospital. J Pharm Pharm Sci. 2006;9:427–433.
  • Zhan C, Correa-de-Araujo R, Bierman AS, et al. Suboptimal prescribing in elderly outpatients: potentially harmful drug–drug and drug-disease combinations. J Am Geriatr Soc. 2005;53:262–267.
  • Juurlink DN, Mamdani M, Kopp A, et al. Drug–drug interactions among elderly patients hospitalized for drug toxicity. JAMA. 2003;289:1652–1658.
  • Moura CS, Acurcio FA, Belo NO. Drug–drug interactions associated with length of stay and cost of hospitalization. J Pharm Pharm Sci. 2009;12:266–272.
  • Langdorf MI, Fox JC, Marwah RS, et al. Physician versus computer knowledge of potential drug interactions in the emergency department. Acad Emerg Med. 2000;7:1321–1329.
  • Andersson ML, Böttiger Y, Lindh JD, et al. Impact of the drug–drug interaction database SFINX on prevalence of potentially serious drug–drug interactions in primary health care. Eur J Clin Pharmacol. 2013;69:565–571.
  • Ko Y, Malone DC, D'Agostino JV, et al. Potential determinants of prescribers’ drug–drug interaction knowledge. Res Social Adm Pharm. 2008;4:355–366.
  • Muurinen SM, Soini HH, Suominen MH, et al. Vision impairment and nutritional status among older assisted living residents. Arch Gerontol Geriatr. 2014;58:384–387.
  • Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373–383.
  • Hughes CP, Berg L, Danziger WL, et al. A new clinical scale for the staging of dementia. Br J Psychiatry. 1982;140:566–572.
  • Guigoz Y, Lauque S, Vellas BJ. Identifying the elderly at risk for malnutrition the mini nutritional assessment. Clin Geriatr Med. 2002;18:737–757.
  • Routasalo PE, Tilvis RS, Kautiainen H, et al. Effects of psychosocial group rehabilitation on social functioning, loneliness and well-being of lonely, older people: randomized controlled trial. J Adv Nurs. 2009;65:297–305.
  • Böttiger Y, Laine K, Andersson ML, et al. SFINX-a drug–drug interaction database designed for clinical decision support systems. Eur J Clin Pharmacol. 2009;65:627–633.
  • Bucşa C, Farcaş A, Cazacu I, et al. How many potential drug–drug interactions cause adverse drug reactions in hospitalized patients? Eur J Intern Med. 2013;24:27–33.
  • Delafuente JC. Understanding and preventing drug interactions in elderly patients. Crit Rev Oncol Hematol. 2003;48:133–143.
  • Teramura-Grönblad M, Bell JS, Pöysti MM, et al. Risk of death associated with use of PPIs in three cohorts of institutionalized older people in Finland. J Am Med Dir Assoc. 2012;13:488.e9–488.e13.
  • Tamblyn R, Reidel K, Patel V. Physicians’ response to computerised alerts for psychotropic drugs in older persons: a multilevel analysis of the associated alert, patient and physician characteristics. BMJ Open. 2012;19:635–643.
  • Ash JS, Berg M, Coiera E. Some unintended consequences of information technology in health care: the nature of patient care information system-related errors. J Am Med Inform Assoc. 2004;11:104–112.
  • Shah NR, Seger AC, Seger DL, et al. Improving acceptance of computerized prescribing alerts in ambulatory care. J Am Med Inform Assoc. 2006;13:5–11.
  • Isaac T, Weissman JS, Davis RB, et al. Overrides of medication alerts in ambulatory care. Arch Intern Med. 2009;169:305–311.
  • Löppönen M, Heinonen P, Jartti L, et al. The appreciation of geriatricians has improved but ability to influence decision-making has declined. (In Finnish). Finnish Med J. 2014;69:991–992.